TAM
ASMB icon

THB Asset Management’s Assembly Biosciences ASMB Stock Holding History

THB Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-16,968
Closed -$3.89M – 243
2013
Q4 		$3.89M Buy
16,968
+1,147
+7% +$209K 0.21% 172
2013
Q3 		$2.74M Sell
15,821
-592
-4% -$90.7K 0.17% 178
2013
Q2 		$2.36M Buy
+16,413
New +$2.57M 0.16% 190

Other funds holding ASMB

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

THB Asset Management's ASMB Position: Q1 2014 in Review

THB Asset Management sold out of Assembly Biosciences (ASMB) in Q1 2014, closing a stake of 16,968 shares — an estimated $3.89M sold.

THB Asset Management first reported a position in ASMB in Q2 2013 and held it in 3 quarters. The position peaked at $3.89M in Q4 2013. 28 funds tracked by Wall St. Rank hold ASMB as of Q1 2014.

  • THB Asset Management reported no remaining Assembly Biosciences position as of Q1 2014 after selling out during the quarter.
  • THB Asset Management sold 16,968 Assembly Biosciences shares in Q1 2014, an estimated $3.89M.
  • THB Asset Management first reported a position in Assembly Biosciences in Q2 2013 and held it in 3 quarters.
  • THB Asset Management's Assembly Biosciences position peaked at $3.89M in Q4 2013.
  • 28 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2014.

Based on THB Asset Management's 13F filing for Q1 2014, filed 22 Apr 2014.